Literature DB >> 35954

Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera.

B Styk, G Russ, K Poláková.   

Abstract

The immune reactivity to both haemagglutinin glycopolypeptides HA1 and HA2 [prepared from bromelain-released haemagglutinin of influenza virus A/Dunedin/4/73 (H3N2)], was demonstrated by both gel double immundiffusion and radioimmunoassay in human convalescent sera obtained after natural infection during influenza epidemics in 1974/75 and 1976/77. In gel double immunodiffusion, the precipitin line(s) corresponding to glycopolypeptide HA1 were always more distinct than precipin line(s) corresponding to glycopolypeptide HA2. In radioimmunoassay, human convalescent sera revealed higher titres for binding of 125-I-labelled HA2 than for 125-I-labelled HA1. Characterization of human convalescent sera was completed by haemagglutination-inhibition test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35954

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  10 in total

1.  Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection.

Authors:  Zuzana Staneková; Vojtech Mucha; Tatiana Sládková; Hana Blaškovičová; František Kostolanský; Eva Varečková
Journal:  Influenza Other Respir Viruses       Date:  2012-01-12       Impact factor: 4.380

2.  Restriction of amino acid change in influenza A virus H3HA: comparison of amino acid changes observed in nature and in vitro.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Ken Tonegawa; Setsuko Nakajima
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

Authors:  E Varecková; V Mucha; F Ciampor; T Betáková; G Russ
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 5.  Passive immune neutralization strategies for prevention and control of influenza A infections.

Authors:  Jianqiang Ye; Hongxia Shao; Daniel R Perez
Journal:  Immunotherapy       Date:  2012-02       Impact factor: 4.196

Review 6.  Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.

Authors:  Zuzana Staneková; Eva Varečková
Journal:  Virol J       Date:  2010-11-30       Impact factor: 4.099

7.  Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Authors:  Miriam Klausberger; Rupert Tscheliessnig; Silke Neff; Raffael Nachbagauer; Teddy John Wohlbold; Monika Wilde; Dieter Palmberger; Florian Krammer; Alois Jungbauer; Reingard Grabherr
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

8.  Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.

Authors:  Javier G Magadán; Meghan O Altman; William L Ince; Heather D Hickman; James Stevens; Aaron Chevalier; David Baker; Patrick C Wilson; Rafi Ahmed; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

9.  Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.

Authors:  Ivan Kosik; Davide Angeletti; James S Gibbs; Matthew Angel; Kazuyo Takeda; Martina Kosikova; Vinod Nair; Heather D Hickman; Hang Xie; Christopher B Brooke; Jonathan W Yewdell
Journal:  J Exp Med       Date:  2019-01-25       Impact factor: 14.307

10.  Antiviral Activities of Compounds Isolated from Pinus densiflora (Pine Tree) against the Influenza A Virus.

Authors:  Thi Kim Quy Ha; Ba Wool Lee; Ngoc Hieu Nguyen; Hyo Moon Cho; Thamizhiniyan Venkatesan; Thi Phuong Doan; Eunhee Kim; Won Keun Oh
Journal:  Biomolecules       Date:  2020-05-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.